Arkolith/Insider Trading/MBRX/Form 4

Foster Jonathan P.

Chief Financial OfficerMoleculin Biotech, Inc. (MBRX) · full profile →Form 4 · filed Jun 23, 2025
Net Buying
Open-Market Buys
$100K
Open-Market Sells
$0
Net Open-Market Flow
$100K
Transactions
8
5 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 23, 2025Buy(P)270K$0.37$100K288K
Jun 22, 2025Tax withholding(F)1K$0.27$28517K
Jun 22, 2025Option exercise(M)4K——18K
Jun 20, 2025Option exercise(M)3K——15K
Jun 20, 2025Tax withholding(F)661$0.27$17814K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 23, 2025Buy(P)811K——1.0M
Jun 22, 2025Option exercise(M)4K—$0228K
Jun 20, 2025Option exercise(M)3K—$0232K

Transaction Codes

P
Open-market purchase
F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-021051) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Moleculin Biotech, Inc.

Build

Ask your agent about MBRX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001437749-25-021051"
Ask your agent
Use Arkolith to summarize insider buying and selling at Moleculin Biotech, Inc.
over the last 90 days and cite the filings.